Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Celgene Corp CELG Stock Holding History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,196	Closed	-$782K	–	63
2018 Q4	$782K	Hold	12,196	–	–	0.78%	32
2018 Q3	$1.01M	Hold	12,196	–	–	0.9%	31
2018 Q2	$1.12M	Hold	12,196	–	–	1.07%	23
2018 Q1	$1.08M	Buy	12,196 +8,143	+201%	+$782K	1.08%	22
2017 Q4	$423K	Buy	+4,053	New	+$457K	0.48%	22

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's CELG Position: Q1 2019 in Review

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 12,196 shares — an estimated $782K sold.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $1.12M in Q2 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold 12,196 Celgene Corp shares in Q1 2019, an estimated $782K.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's Celgene Corp position peaked at $1.12M in Q2 2018.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's 13F filing for Q1 2019, filed 13 May 2019.